Rouzbeh Fateh, MD
Neurology · South San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Offices
- 3
Offices
3 locations · Permanente Medical Group Inc · County of San Mateo
Hospitals listed: Banner North Colorado Medical Center · San Mateo Medical Center. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Fateh’s office at (650) 742-2000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A174833 · Current
Licensed to practise in California · since 2021 · expires 2027-09-30 · Tehran University of Medical Sciences and Health Services.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Banner North Colorado Medical CenterGreeley, COAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Banner Health, which runs 33 hospitals in 6 statesPatients rate it 3 of 5 · 65% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.142, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Banner North Colorado Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 9 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.142 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.35 to 2.33) · 540 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.11 (0.74 to 1.48) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 187.85 (135.11 to 240.6) · 70 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 30 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.2 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.6 · 91 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.6 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.7 · 96 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 1,395 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.23 (0.01 to 0.44) · 2,575 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.33 (0.12 to 0.53) · 2,611 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.82 (2.65 to 7) · 894 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.28 to 3.56) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (1.06 to 4.11) · 856 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.46 (1.46 to 17.47) · 251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.73 (2.77 to 10.7) · 257 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.25 (0.79 to 3.72) · 184 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.51 (0 to 1.33) · 2,142 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.1 · 28 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.429 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.515 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.553 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.8 · 160 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.2 · 285 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -29.4 · 104 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -34.5 · 179 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 32.6 · 164 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 314 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.6 (4.5 to 9.6) · 144 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (7.3 to 13.6) · 144 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 30 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 39 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 87 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.5) · 504 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 255 cases | No different | Jan 2024 – Dec 2024 |
What patients said (557 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 3 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 69% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 65% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for San Mateo Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.25 to 2.43) · 45 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.48 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 258 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 379 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (0.82 to 6.05) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (0.92 to 4.37) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.76) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.661 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 25 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.9) · 167 cases | No different | Jan 2022 – Dec 2024 |
What patients said (208 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$63,312
Medicare paid this office $63,312 for 315 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 110 | $19,691 | $125 |
| New patient visit (60+ min) | 60 | $8,201 | $137 |
| New patient visit (60+ min) | 37 | $5,247 | $142 |
| Long return visit (40+ min) | 32 | $3,880 | $114 |
| Muscle electrical test | 51 | $2,971 | $38 |
See all 14 services
| Long return visit (40+ min) | 110 | $19,691 | $125 |
| New patient visit (60+ min) | 60 | $8,201 | $137 |
| New patient visit (60+ min) | 37 | $5,247 | $142 |
| Long return visit (40+ min) | 32 | $3,880 | $114 |
| Muscle electrical test | 51 | $2,971 | $38 |
| Muscle electrical test | 50 | $2,688 | $37 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 59 | $2,277 | $26 |
| Nerve test | 12 | $1,993 | $166 |
| Return visit (30+ min) | 20 | $1,627 | $81 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 39 | $1,462 | $25 |
| Nerve test | 14 | $1,304 | $93 |
| Nerve test | 17 | $1,071 | $63 |
| New patient visit (45+ min) | 12 | $963 | $80 |
| Muscle electrical test | 13 | $197 | $15 |
Who their Medicare patients are
315 Original Medicare patients in 2024. Average age 75 · Under 65 6% · 85 and older 13% · Women 55% · Also on Medicaid 17% · Health risk score 1.33. At or below the middle of the specialty; the typical neurology clinician is at 1.61.
Conditions among them: High blood pressure 70% · Diabetes 30% · Chronic kidney disease 26% · Coronary heart disease 23% · Depression 22% · Atrial fibrillation 17% · Cancer 16% · Stroke 14% · Heart failure 13% · Dementia 13% · COPD 11%.
The office billed $1,033,884, Medicare allowed $87,858 and paid $63,312; for 802 services of 26 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 315 | 802 | 75 | 1.33 | $1,033,884 | $63,312 |
| 2023 | 337 | 882 | 75 | 1.28 | $1,121,612 | $79,561 |
| 2022 | 155 | 255 | 73 | 1.32 | $135,301 | $23,337 |
| 2021 | 132 | 288 | 68 | 1.49 | $97,811 | $28,954 |
| 2020 | 143 | 309 | 68 | 1.61 | $85,127 | $25,035 |
| 2019 | 152 | 340 | 67 | 1.48 | $102,784 | $29,603 |
| 2018 | 94 | 133 | 69 | 1.69 | $43,941 | $12,680 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| New patient visit (60+ min) | 130 | $19,626 | $151 |
| Long return visit (40+ min) | 94 | $17,270 | $128 |
| Long return visit (40+ min) | 41 | $7,299 | $133 |
| New patient visit (60+ min) | 30 | $4,659 | $155 |
| Muscle electrical test | 57 | $3,129 | $40 |
| Muscle electrical test | 43 | $2,805 | $42 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 70 | $2,682 | $28 |
| Nerve test | 12 | $1,886 | $157 |
| Nerve test | 17 | $1,737 | $102 |
| Return visit (30+ min) | 21 | $1,716 | $78 |
| Return visit (30+ min) | 15 | $1,599 | $89 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 27 | $1,421 | $28 |
| Nerve test | 14 | $1,206 | $86 |
| Nerve test | 13 | $1,162 | $89 |
| Nerve test | 15 | $1,020 | $68 |
2022: 5 services
| New patient visit (60+ min) | 27 | $4,210 | $156 |
| Return visit (30+ min) | 33 | $4,010 | $95 |
| Short return visit (20+ min) | 36 | $2,393 | $63 |
| New patient visit (45+ min) | 16 | $2,048 | $128 |
| Muscle electrical test | 27 | $1,937 | $51 |
2021: 6 services
| Return visit (30+ min) | 68 | $9,885 | $98 |
| Long return visit (40+ min) | 17 | $3,537 | $147 |
| Muscle electrical test | 19 | $2,423 | $90 |
| New patient visit (45+ min) | 17 | $1,899 | $112 |
| Muscle electrical test | 17 | $911 | $40 |
| Short return visit (20+ min) | 13 | $894 | $64 |
2020: 7 services
| Return visit (30+ min) | 66 | $7,446 | $81 |
| Long return visit (40+ min) | 21 | $3,124 | $125 |
| New patient visit (45+ min) | 19 | $2,618 | $138 |
| Short return visit (20+ min) | 22 | $1,364 | $57 |
| Muscle electrical test | 21 | $1,024 | $35 |
| New patient visit (30+ min) | 11 | $954 | $87 |
| Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 12 | $111 | $9 |
2019: 5 services
| Return visit (30+ min) | 68 | $8,520 | $83 |
| Long return visit (40+ min) | 43 | $6,275 | $110 |
| New patient visit (30+ min) | 14 | $1,281 | $91 |
| Muscle electrical test | 22 | $1,026 | $37 |
| Short return visit (20+ min) | 13 | $761 | $54 |
2018: 4 services
| Long return visit (40+ min) | 25 | $3,169 | $122 |
| New patient visit (45+ min) | 20 | $2,789 | $139 |
| Return visit (30+ min) | 24 | $2,266 | $87 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $945 | $86 |
Medicaid work
$3,244 in 2022
Medicaid paid $3,244 for 96 billed services this clinician did in 2022, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Muscle electrical test | 38 | $1,803 |
| Short return visit (20+ min) | 43 | $1,116 |
| Return visit (30+ min) | 15 | $325 |
| 2022 | 96 | 3 | 14 | $3,244 |
| 2021 | 337 | 3 | 25 | $12,495 |
| 2020 | 303 | 3 | 23 | $11,501 |
| 2019 | 403 | 3 | 28 | $15,207 |
| 2018 | 110 | 3 | 21 | $6,969 |
See the largest Medicaid services in earlier years
2021
| Return visit (30+ min) | 193 | $6,808 |
| Muscle electrical test | 131 | $4,880 |
| Nerve test | 13 | $808 |
2020
| Return visit (30+ min) | 172 | $6,332 |
| Muscle electrical test | 118 | $4,505 |
| New patient visit (30+ min) | 13 | $664 |
2019
| Return visit (30+ min) | 259 | $8,911 |
| Long return visit (40+ min) | 75 | $3,379 |
| Muscle electrical test | 69 | $2,917 |
2018
| Long return visit (40+ min) | 67 | $3,416 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 25 | $2,708 |
| Return visit (30+ min) | 18 | $845 |
Drugs they prescribed that Part D paid
$135,352
Pharmacies billed $135,352 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 562) in 2024. At or below the middle of the specialty; the typical neurology clinician is at 0%.
532 generic and 30 brand-name prescriptions · $135,352 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Memantine | 57 | $1,693 | $30 |
| Carbidopa-Levodopa | 67 | $1,069 | $16 |
| Gabapentin | 65 | $1,033 | $16 |
| Propranolol Hcl Er | 12 | $889 | $74 |
| Pregabalin | 19 | $675 | $36 |
See all 13 drugs
| Memantine | 57 | $1,693 | $30 |
| Carbidopa-Levodopa | 67 | $1,069 | $16 |
| Gabapentin | 65 | $1,033 | $16 |
| Propranolol Hcl Er | 12 | $889 | $74 |
| Pregabalin | 19 | $675 | $36 |
| Duloxetine | 24 | $589 | $25 |
| Donepezil | 53 | $452 | $9 |
| Levetiracetam | 12 | $347 | $29 |
| Topiramate | 31 | $318 | $10 |
| Prednisone | 15 | $288 | $19 |
| Atorvastatin | 14 | $272 | $19 |
| Amitriptyline | 14 | $159 | $11 |
| Trazodone | 11 | $42 | $4 |
Year by year
| 2024 | 562 | 136 | 0% (0) | 5% | $135,352 |
| 2023 | 461 | 137 | 0% (0) | None | $104,878 |
| 2022 | 986 | 169 | 0% (0) | None | $121,715 |
| 2021 | 1,297 | 176 | None | 11% | $154,192 |
| 2020 | 1,284 | 186 | None | 10% | $145,109 |
| 2019 | 1,090 | 144 | None | 9% | $97,544 |
| 2018 | 292 | 88 | None | None | $21,674 |
| 2017 | 54 | 16 | None | None | $4,893 |
| 2016 | 72 | 14 | 0% (0) | None | $2,223 |
| 2015 | 73 | 21 | 0% (0) | None | $4,332 |
| 2014 | 96 | 14 | None | 16% | $3,859 |
| 2013 | 11 | None | 0% (0) | None | $727 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Memantine | 39 | $1,509 | $39 |
| Gabapentin | 38 | $1,443 | $38 |
| Carbidopa-Levodopa | 54 | $1,369 | $25 |
| Pyridostigmine | 11 | $1,315 | $120 |
| Topiramate | 53 | $1,150 | $22 |
| Donepezil | 40 | $1,134 | $28 |
| Levetiracetam | 37 | $692 | $19 |
| Atorvastatin | 11 | $345 | $31 |
| Baclofen | 15 | $331 | $22 |
| Tizanidine | 15 | $253 | $17 |
| Duloxetine | 14 | $183 | $13 |
| Prednisone | 11 | $144 | $13 |
2022: 22 drugs
| Aimovig | Migraine | 40 | $50,868 | $1,272 |
| Emgality | Migraine | 28 | $21,506 | $768 |
| Gabapentin | None | 129 | $6,380 | $49 |
| Pyridostigmine | None | 43 | $4,412 | $103 |
| Levetiracetam | None | 90 | $4,073 | $45 |
| Mycophenolate Mofetil | None | 26 | $3,097 | $119 |
| Topiramate | None | 108 | $2,504 | $23 |
| Memantine | None | 47 | $2,338 | $50 |
| Azathioprine | None | 13 | $2,284 | $176 |
| Lidocaine | None | 47 | $1,995 | $42 |
| Pregabalin | None | 17 | $1,366 | $80 |
| Primidone | None | 20 | $1,051 | $53 |
| Lamotrigine | None | 49 | $1,025 | $21 |
| Duloxetine | None | 49 | $919 | $19 |
| Rosuvastatin | None | 20 | $866 | $43 |
| Carbidopa-Levodopa | None | 29 | $803 | $28 |
| Donepezil | None | 44 | $691 | $16 |
| Prednisone | None | 21 | $293 | $14 |
| Atorvastatin | None | 15 | $283 | $19 |
| Sumatriptan | None | 15 | $197 | $13 |
| Clopidogrel | None | 11 | $164 | $15 |
| Butalbital-Acetaminophen-Caffe | None | 11 | $143 | $13 |
2021: 34 drugs
| Aimovig | Migraine | 72 | $51,593 | $717 |
| Emgality | Migraine | 19 | $19,570 | $1,030 |
| Emgality | Migraine | 23 | $14,998 | $652 |
| Vimpat | None | 14 | $14,172 | $1,012 |
| Levetiracetam | None | 117 | $6,504 | $56 |
| Gabapentin | None | 101 | $4,625 | $46 |
| Lidocaine | None | 72 | $3,975 | $55 |
| Memantine | None | 58 | $3,793 | $65 |
| Pyridostigmine | None | 52 | $3,562 | $68 |
| Pregabalin | None | 33 | $2,716 | $82 |
| Topiramate | None | 122 | $2,566 | $21 |
| Ethosuximide | None | 11 | $2,543 | $231 |
| Azathioprine | None | 11 | $1,914 | $174 |
| Mycophenolate Mofetil | None | 22 | $1,898 | $86 |
| Lamotrigine | None | 66 | $1,426 | $22 |
| Carbidopa-Levodopa | None | 35 | $1,275 | $36 |
| Carbamazepine Er | None | 22 | $1,065 | $48 |
| Baclofen | None | 17 | $1,021 | $60 |
| Phenobarbital | None | 21 | $918 | $44 |
| Primidone | None | 17 | $858 | $50 |
| Duloxetine | None | 29 | $837 | $29 |
| Donepezil | None | 71 | $801 | $11 |
| Rosuvastatin | None | 15 | $705 | $47 |
| Prednisone | None | 44 | $658 | $15 |
| Atorvastatin | None | 23 | $539 | $23 |
| Butalbital-Acetaminophen-Caffe | None | 29 | $414 | $14 |
| Pantoprazole | None | 17 | $322 | $19 |
| Nortriptyline | None | 11 | $279 | $25 |
| Alendronate | None | 15 | $163 | $11 |
| Sulfamethoxazole-Trimethoprim | None | 12 | $136 | $11 |
| Sumatriptan | None | 11 | $123 | $11 |
| Diazepam | None | 11 | $74 | $7 |
| Clopidogrel | None | 18 | $60 | $3 |
| Simvastatin | None | 12 | $54 | $5 |
2020: 30 drugs
| Aimovig | Migraine | 41 | $31,025 | $757 |
| Emgality | Migraine | 22 | $17,235 | $783 |
| Carbamazepine Er | None | 36 | $4,753 | $132 |
| Gabapentin | None | 96 | $4,534 | $47 |
| Memantine Hcl Er | None | 15 | $4,526 | $302 |
| Pregabalin | None | 39 | $4,518 | $116 |
| Levetiracetam | None | 122 | $4,508 | $37 |
| Memantine | None | 49 | $4,028 | $82 |
| Pyridostigmine | None | 41 | $3,223 | $79 |
| Topiramate | None | 123 | $2,367 | $19 |
| Carbidopa-Levodopa | None | 51 | $2,210 | $43 |
| Carbidopa-Levodopa Er | None | 11 | $1,838 | $167 |
| Lidocaine | None | 39 | $1,592 | $41 |
| Donepezil | None | 105 | $1,348 | $13 |
| Divalproex | None | 16 | $1,156 | $72 |
| Lamotrigine | None | 40 | $1,049 | $26 |
| Mycophenolate Mofetil | None | 11 | $962 | $87 |
| Propranolol | None | 12 | $902 | $75 |
| Phenobarbital | None | 22 | $859 | $39 |
| Primidone | None | 18 | $814 | $45 |
| Butalbital-Acetaminophen-Caffe | None | 26 | $543 | $21 |
| Ropinirole | None | 11 | $485 | $44 |
| Baclofen | None | 12 | $463 | $39 |
| Prednisone | None | 43 | $448 | $10 |
| Atorvastatin | None | 34 | $349 | $10 |
| Nortriptyline | None | 12 | $279 | $23 |
| Clopidogrel | None | 36 | $224 | $6 |
| Simvastatin | None | 13 | $212 | $16 |
| Amitriptyline | None | 12 | $177 | $15 |
| Diazepam | None | 14 | $109 | $8 |
2019: 27 drugs
| Aimovig | Migraine | 27 | $17,549 | $650 |
| Carbamazepine Er | None | 41 | $7,373 | $180 |
| Memantine Hcl Er | None | 32 | $6,845 | $214 |
| Levetiracetam | None | 142 | $3,405 | $24 |
| Gabapentin | None | 96 | $3,143 | $33 |
| Pregabalin | None | 13 | $2,849 | $219 |
| Carbidopa-Levodopa Er | None | 13 | $2,164 | $166 |
| Topiramate | None | 115 | $1,900 | $17 |
| Divalproex | None | 20 | $1,772 | $89 |
| Carbidopa-Levodopa | None | 51 | $1,603 | $31 |
| Dalfampridine Er | None | 11 | $1,266 | $115 |
| Propranolol | None | 23 | $1,200 | $52 |
| Donepezil | None | 97 | $1,054 | $11 |
| Pyridostigmine | None | 11 | $1,015 | $92 |
| Memantine | None | 12 | $908 | $76 |
| Lidocaine | None | 13 | $848 | $65 |
| Escitalopram | None | 16 | $708 | $44 |
| Butalbital-Acetaminophen-Caffe | None | 30 | $648 | $22 |
| Phenobarbital | None | 20 | $578 | $29 |
| Lamotrigine | None | 30 | $548 | $18 |
| Ezetimibe | None | 16 | $518 | $32 |
| Atorvastatin | None | 27 | $444 | $16 |
| Ropinirole | None | 13 | $439 | $34 |
| Clopidogrel | None | 27 | $281 | $10 |
| Sumatriptan | None | 20 | $244 | $12 |
| Diazepam | None | 11 | $91 | $8 |
| Simvastatin | None | 11 | $77 | $7 |
2018: 8 drugs
| Levetiracetam | 22 | $620 | $28 |
| Carbidopa-Levodopa | 20 | $615 | $31 |
| Topiramate | 23 | $442 | $19 |
| Prednisone | 25 | $341 | $14 |
| Gabapentin | 22 | $233 | $11 |
| Donepezil | 21 | $214 | $10 |
| Clopidogrel | 14 | $142 | $10 |
| Sumatriptan | 12 | $130 | $11 |
2016: 1 drug
| Atorvastatin | 11 | $176 | $16 |
2015: 1 drug
| Atorvastatin | 11 | $1,170 | $106 |
Money from drug and device companies
$170 in 2022
| 2022 | 2 | 9 | None | $170 |
| 2020 | 1 | 1 | None | $11 |
| 2019 | 5 | 15 | None | $909 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Abbvie | Ubrelvy | $148 | 8 payments
|
| Biohaven Pharmaceutical Holding Company | Nurtec Odt | $21 | 1 payment
|
See all 9 published payments
| Abbvie | Meals · 2022-10-18 | Ubrelvy | $29 |
| Abbvie | Meals · 2022-09-14 | Qulipta | $12 |
| Abbvie | Meals · 2022-05-31 | Ubrelvy | $22 |
| Abbvie | Meals · 2022-05-14 | Qulipta | $13 |
| Abbvie | Meals · 2022-04-29 | Qulipta | $16 |
| Abbvie | Meals · 2022-04-25 | Qulipta | $12 |
| Biohaven Pharmaceutical Holding Company | Meals · 2022-04-20 | Nurtec Odt | $21 |
| Abbvie | Meals · 2022-03-10 | Ubrelvy | $24 |
| Abbvie | Meals · 2022-02-07 | Ubrelvy | $21 |
See earlier years (2020, 2019)
2020: $11
| Akcea Therapeutics | Tegsedi | $11 | 1 payment
|
2019: $909
| Amgen | Aimovig | $349 | 6 payments
|
| Akcea Therapeutics | Tegsedi | $272 | 3 payments
|
| Allergan | Botox | $217 | 4 payments
|
| Ucb | Briviact | $44 | 1 payment
|
| EMD Serono | Mavenclad | $27 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.4 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1215270533
- Licence
- CA A174833, CT 56992California A174833: Current · expires 2027-09-30
- Group
- Permanente Medical Group Inc · County of San Mateo
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Neurology (2084N0400X); Federal specialty code 204R00000X (204R00000X); Federal specialty code 2084N0008X (2084N0008X); Federal specialty code 2084N0600X (2084N0600X)
- Mailing address
- 5820 Owens Dr, Bldg E, Fl 2, Pleasanton, CA, 94588
- NPI first listed
- 2013-04-04
- NPI last updated
- 2025-05-09
- NPI record certified
- 2025-05-09
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 435 Lewis Ave, Meriden, CT, 06451 · 300 Pasteur Dr, Stanford, CA, 94305
This office lists an electronic records connection.